Literature DB >> 10743729

Characteristics of Acinetobacter strains (phenotype classification, antibiotic susceptibility and production of beta-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc.

P Hejnar1, M Kolár, V Hájek.   

Abstract

A total of 85 strains of the genus Acinetobacter were isolated from haemocultures at the Institute of Microbiology of the Teaching Hospital in Olomouc over the period January 1993 to June 1997. Sixty-two (73.0%) strains of the Acinetobacter calcoaceticus-baumannii complex (Acb complex) were the most frequent. In 3 (3.5%) strains it was impossible to decide whether they belonged to the Acb complex. Other acinetobacter species were represented by 20 (23.5%) strains. The greatest amount (28.2%) of these strains was collected from the Clinic of Internal Medicine. Leukemias, lymphomas and myelodysplastic syndromes were the most frequent clinical diagnoses (20.0%) of the patients with a positive haemoculture. The most effective antimicrobial preparations tested were as follows: meropenem (98.8% of susceptible strains), colistin (94.1%), quinolones (90.6-94.1% according to the type of agent) and amikacin (91.8%). The Acb complex strains were less susceptible to antimicrobial agents than other acinetobacters. Production of inductive chromosomal beta-lactamases AmpC was proved in 42 (49.4%) strains whilst no occurrence of extended-spectrum beta-lactamases (ESBL) in the isolated organisms was recorded.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10743729

Source DB:  PubMed          Journal:  Acta Univ Palacki Olomuc Fac Med        ISSN: 0301-2514


  13 in total

1.  Rate of polymyxin resistance among Acinetobacter baumannii recovered from hospitalized patients: a systematic review and meta-analysis.

Authors:  William Gustavo Lima; Júlio César Moreira Brito; Bárbara Gatti Cardoso; Valbert Nascimento Cardoso; Magna Cristina de Paiva; Maria Elena de Lima; Simone Odília Antunes Fernandes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-06-12       Impact factor: 3.267

Review 2.  Resistance mechanisms.

Authors:  Yasemin Cag; Hulya Caskurlu; Yanyan Fan; Bin Cao; Haluk Vahaboglu
Journal:  Ann Transl Med       Date:  2016-09

3.  Isolation and identification of Acinetobacter species with special reference to antibiotic resistance.

Authors:  Neetu Gupta; Nageswari Gandham; Savita Jadhav; Ravindra Nath Mishra
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

4.  Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study.

Authors:  Gul R Yilmaz; Murat Dizbay; Tumer Guven; Husnu Pullukcu; Meltem Tasbakan; Ozlem Tunccan Guzel; Yasemin T Tekce; Mehmet Ozden; Ozge Turhan; Rahmet Guner; Yasemin Cag; Fatma Bozkurt; Fatma Yilmaz Karadag; Elif Doyuk Kartal; Gokhan Gozel; Cemal Bulut; Sebnem Erdinc; Siran Keske; Ziya Cibali Acikgoz; Mehmet A Tasyaran
Journal:  Ann Saudi Med       Date:  2016 May-Jun       Impact factor: 1.526

Review 5.  Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities.

Authors:  Muhammad Asif; Iqbal Ahmad Alvi; Shafiq Ur Rehman
Journal:  Infect Drug Resist       Date:  2018-08-21       Impact factor: 4.003

6.  Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016).

Authors:  Ana C Gales; Harald Seifert; Deniz Gur; Mariana Castanheira; Ronald N Jones; Helio S Sader
Journal:  Open Forum Infect Dis       Date:  2019-03-15       Impact factor: 3.835

7.  Emergent Polymyxin Resistance: End of an Era?

Authors:  Zekun Li; Yuping Cao; Lingxian Yi; Jian-Hua Liu; Qiwen Yang
Journal:  Open Forum Infect Dis       Date:  2019-10-01       Impact factor: 3.835

8.  In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital.

Authors:  Yongyut Lertsrisatit; Wichai Santimaleeworagun; Sudaluck Thunyaharn; Jantima Traipattanakul
Journal:  Infect Drug Resist       Date:  2017-11-20       Impact factor: 4.003

Review 9.  Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Ilda Barbu Czobor; Mariana Carmen Chifiriuc
Journal:  Microorganisms       Date:  2020-06-21

10.  New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.

Authors:  Bingbing Sun; Haiyan Liu; Yu Jiang; Lei Shao; Sheng Yang; Daijie Chen
Journal:  mSphere       Date:  2020-04-01       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.